Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis

Detalhes bibliográficos
Autor(a) principal: Correia, Andreza Veruska Lira
Data de Publicação: 2009
Outros Autores: Cazal, Cláudia, Leão, Jair Carneiro, Ribeiro, Camila Maria Beder, Castro, Jurema Freire Lisboa de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1561
Resumo: Mucositis is an acute inflammation of the oral mucosa in response to the cytotoxic action of chemotherapy and/or radiotherapy regimens. It is a debilitating side effect and a dose-limiting complication that impact on local control and survival rate as well as on the quality of life of cancer patients. This study aimed to correlate the degree of oral mucositis to the presence of Human Herpes Virus 1 DNA in patients with squamous cell carcinoma treated through conventional radiotherapy. The sample was made up of 33 patients with malignant tumors of the head and neck submitted to radiotherapy treatment through either electron teleradiotherapy or cobalt therapy, with fractioned dose ranging from 180 to 200cGy on the right and left cervical-facial regions and supraclavicular fossa. Swabs were collected in order to detect Human Herpes Virus 1 DNA using polymerase chain reaction assays. Patients were examined beginning with the second week of therapy and were followed up on a weekly basis until the end of treatment and classified for oral mucositis criteria according to the World Health Organization. Among the 33 patients evaluated, 2 (6.1%) showed no clinical evidence of mucositis; 8 (24.2%) had Grade I mucositis; 11 (33.3%) had Grade II; 11 (33.3%) had Grade III; and one (3.0%) had Grade IV. Human Herpes Virus 1 and Epstein Barr virus were identified in the sample analyzed. However, these findings demonstrated no statistically significant correlation to the exacerbation of radio-induced oral mucositis.
id INCA-1_e5296d708534a3243ed40614adf6dabf
oai_identifier_str oai:rbc.inca.gov.br:article/1561
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral MocositisEvaluación de la presencia del AND viral del Herpesvirus Humano 1 en pacientes con Mucositis OralAvaliação da Presença do DNA Viral do Herpes-Vírus Humano 1 em Pacientes Portadores de Mucosite OralEstomatiteNeoplasias BucaisHerpes-Vírus Humano 1RadioterapiaStomatitisMouth NeoplasmsHerpesvirus 1, HumanRadiotherapyEstomatitisNeoplasias de la BocaHerpesvirus Humano 1RadioterapiaMucositis is an acute inflammation of the oral mucosa in response to the cytotoxic action of chemotherapy and/or radiotherapy regimens. It is a debilitating side effect and a dose-limiting complication that impact on local control and survival rate as well as on the quality of life of cancer patients. This study aimed to correlate the degree of oral mucositis to the presence of Human Herpes Virus 1 DNA in patients with squamous cell carcinoma treated through conventional radiotherapy. The sample was made up of 33 patients with malignant tumors of the head and neck submitted to radiotherapy treatment through either electron teleradiotherapy or cobalt therapy, with fractioned dose ranging from 180 to 200cGy on the right and left cervical-facial regions and supraclavicular fossa. Swabs were collected in order to detect Human Herpes Virus 1 DNA using polymerase chain reaction assays. Patients were examined beginning with the second week of therapy and were followed up on a weekly basis until the end of treatment and classified for oral mucositis criteria according to the World Health Organization. Among the 33 patients evaluated, 2 (6.1%) showed no clinical evidence of mucositis; 8 (24.2%) had Grade I mucositis; 11 (33.3%) had Grade II; 11 (33.3%) had Grade III; and one (3.0%) had Grade IV. Human Herpes Virus 1 and Epstein Barr virus were identified in the sample analyzed. However, these findings demonstrated no statistically significant correlation to the exacerbation of radio-induced oral mucositis.La mucositis es considerada una afección aguda de la mucosa oral en respuesta a la acción citotóxica de agentes quimioterápicos y/o radioterápicos. Representa un efecto colateral debilitante y una complicación dosis-limitante, que tiene impacto tanto en el control local como en la supervivencia y en la calidad de vida de los pacientes oncológicos. Este trabajo tuvo como objetivo la correlación de los grados de la mucositis oral con la presencia del ADN viral del Herpesvirus Humano 1 en pacientes con carcinoma espinocelular tratados con radioterapia convencional. La muestra se compuso de 33 pacientes portadores de neoplasia maligna de cabeza y cuello sometidos a tratamiento radioterápico a través de telerradioterapia de electrones o cobaltoterapia, con dosis fraccionada variando entre 180 y 200cGy en el área cérvico-facial derecha e izquierda y la fosa supraclavicular. Fue realizada una colecta de frotamiento para detectar el ADN del virus HSV 1 por reacción en cadena de la polimerasa. Los pacientes fueron examinados a partir de la segunda semana de tratamiento y fueron seguidos por todas las semanas hasta el final de las aplicaciones, y clasificados de acuerdo a los criterios de la mucositis oral de la Organización Mundial de la Salud. De los 33 pacientes evaluados, 2 (6,1%) no presentaron evidencia clínica de mucositis, 8 (24,2%) presentaron mucositis grado I, 11 (33,3%) grado II, 11 (33,3%) grado III y 1 (3,0%) grado IV. Para la muestra analizada se identificó la presencia del herpesvirus humano 1 y virus de Epstein Barr, sin embargo, esos hallazgos no demostraron relación estadísticamente significativa con el agravamiento de la mucositis oral radioinducida.A mucosite é considerada uma afecção aguda da mucosa oral em resposta à ação citotóxica de agentes quimioterápicos e/ou radioterápicos. Representa um efeito colateral debilitante, sendo uma complicação doselimitante que tem impacto tanto no controle local quanto na sobrevida e na qualidade de vida de pacientes oncológicos. Este trabalho teve o objetivo de correlacionar os graus de mucosite oral à presença do DNA viral do Herpes-vírus Humano 1 em pacientes portadores de carcinoma espinocelular tratados através de radioterapia convencional. A amostra foi composta por 33 pacientes portadores de neoplasia maligna de cabeça e pescoço, submetidos a tratamento radioterápico através de telerradioterapia de elétrons ou cobaltoterapia, com dose fracionada variando entre 180 e 200cGy nas áreas cervicofacial direita e esquerda e fossa supraclavicular. Foi realizada coleta de esfregaço para detecção de DNA do vírus HSV 1 através da reação em cadeia da polimerase. Os pacientes foram examinados a partir da segunda semana de tratamento, sendo acompanhados, semanalmente, até o término das aplicações, e classificados de acordo com os critérios de mucosite oral da Organização Mundial da Saúde. Dos 33 pacientes avaliados, 2 (6,1%) não apresentaram evidência clínica de mucosite, 8 (24,2%) tinham mucosite grau I, 11 (33,3%) grau II, 11 (33,3%) grau III e 1 (3,0%) grau IV. Para a amostra analisada, foram identificadas a presença do Herpes-vírus Humano 1 e vírus Epstein Barr, entretanto, esses achados não demonstraram relação estatisticamente significante com o agravamento da mucosite oral radioinduzida.INCA2009-12-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/156110.32635/2176-9745.RBC.2009v55n4.1561Revista Brasileira de Cancerologia; Vol. 55 No. 4 (2009): Oct./Nov./Dec.; 321-328Revista Brasileira de Cancerologia; Vol. 55 Núm. 4 (2009): oct./nov./dic.; 321-328Revista Brasileira de Cancerologia; v. 55 n. 4 (2009): out./nov./dez; 321-3282176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/1561/934Correia, Andreza Veruska Lira Cazal, Cláudia Leão, Jair Carneiro Ribeiro, Camila Maria BederCastro, Jurema Freire Lisboa de info:eu-repo/semantics/openAccess2021-11-29T20:20:13Zoai:rbc.inca.gov.br:article/1561Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:20:13Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
Evaluación de la presencia del AND viral del Herpesvirus Humano 1 en pacientes con Mucositis Oral
Avaliação da Presença do DNA Viral do Herpes-Vírus Humano 1 em Pacientes Portadores de Mucosite Oral
title Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
spellingShingle Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
Correia, Andreza Veruska Lira
Estomatite
Neoplasias Bucais
Herpes-Vírus Humano 1
Radioterapia
Stomatitis
Mouth Neoplasms
Herpesvirus 1, Human
Radiotherapy
Estomatitis
Neoplasias de la Boca
Herpesvirus Humano 1
Radioterapia
title_short Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
title_full Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
title_fullStr Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
title_full_unstemmed Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
title_sort Assessing the Presence of Viral DNA from Human Herpes Virus 1 in Patients with Oral Mocositis
author Correia, Andreza Veruska Lira
author_facet Correia, Andreza Veruska Lira
Cazal, Cláudia
Leão, Jair Carneiro
Ribeiro, Camila Maria Beder
Castro, Jurema Freire Lisboa de
author_role author
author2 Cazal, Cláudia
Leão, Jair Carneiro
Ribeiro, Camila Maria Beder
Castro, Jurema Freire Lisboa de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Correia, Andreza Veruska Lira
Cazal, Cláudia
Leão, Jair Carneiro
Ribeiro, Camila Maria Beder
Castro, Jurema Freire Lisboa de
dc.subject.por.fl_str_mv Estomatite
Neoplasias Bucais
Herpes-Vírus Humano 1
Radioterapia
Stomatitis
Mouth Neoplasms
Herpesvirus 1, Human
Radiotherapy
Estomatitis
Neoplasias de la Boca
Herpesvirus Humano 1
Radioterapia
topic Estomatite
Neoplasias Bucais
Herpes-Vírus Humano 1
Radioterapia
Stomatitis
Mouth Neoplasms
Herpesvirus 1, Human
Radiotherapy
Estomatitis
Neoplasias de la Boca
Herpesvirus Humano 1
Radioterapia
description Mucositis is an acute inflammation of the oral mucosa in response to the cytotoxic action of chemotherapy and/or radiotherapy regimens. It is a debilitating side effect and a dose-limiting complication that impact on local control and survival rate as well as on the quality of life of cancer patients. This study aimed to correlate the degree of oral mucositis to the presence of Human Herpes Virus 1 DNA in patients with squamous cell carcinoma treated through conventional radiotherapy. The sample was made up of 33 patients with malignant tumors of the head and neck submitted to radiotherapy treatment through either electron teleradiotherapy or cobalt therapy, with fractioned dose ranging from 180 to 200cGy on the right and left cervical-facial regions and supraclavicular fossa. Swabs were collected in order to detect Human Herpes Virus 1 DNA using polymerase chain reaction assays. Patients were examined beginning with the second week of therapy and were followed up on a weekly basis until the end of treatment and classified for oral mucositis criteria according to the World Health Organization. Among the 33 patients evaluated, 2 (6.1%) showed no clinical evidence of mucositis; 8 (24.2%) had Grade I mucositis; 11 (33.3%) had Grade II; 11 (33.3%) had Grade III; and one (3.0%) had Grade IV. Human Herpes Virus 1 and Epstein Barr virus were identified in the sample analyzed. However, these findings demonstrated no statistically significant correlation to the exacerbation of radio-induced oral mucositis.
publishDate 2009
dc.date.none.fl_str_mv 2009-12-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1561
10.32635/2176-9745.RBC.2009v55n4.1561
url https://rbc.inca.gov.br/index.php/revista/article/view/1561
identifier_str_mv 10.32635/2176-9745.RBC.2009v55n4.1561
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1561/934
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 55 No. 4 (2009): Oct./Nov./Dec.; 321-328
Revista Brasileira de Cancerologia; Vol. 55 Núm. 4 (2009): oct./nov./dic.; 321-328
Revista Brasileira de Cancerologia; v. 55 n. 4 (2009): out./nov./dez; 321-328
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042247374471168